NantKwest Appoints VP Of Research And Clinical Development
This article was originally published in Scrip
Executive Summary
NantKwest, an immunotherapy company focused on the immune system, has appointed Fatih M. Uckun vice president of research and clinical development. Prior to joining NantKwest, Uckun was president of Ares Pharmaceuticals and he was also a professor in the department of pediatrics at the Keck School of Medicine of the University of Southern California and head of translational research in leukemia and lymphoma of the Children’s Center for Cancer and Blood Diseases.